Science Inventory

Identification of Absorption, Distribution, Metabolism, and Excretion (ADME) Genes Relevant to Steatosis Using a Gene Expression Approach


Abedini, J., A. Walsh, AND H. El-Masri. Identification of Absorption, Distribution, Metabolism, and Excretion (ADME) Genes Relevant to Steatosis Using a Gene Expression Approach. Society of Toxicology, San Antonio, Texas, March 11 - 15, 2018.


This work highlights the application of bioinformatics tools to identify genes that are modulated by adverse outcomes. Specifically, we delineate a method to identify genes that are related to ADME and can impact target tissue dose in response to chemical exposures. The computational method outlined in this work is applicable to any adverse outcome pathway, and provide a linkage between chemical exposure, target tissue dose, and adverse outcomes. Application of this method will allow for the rapid screening of chemicals for their impact on ADME-related genes using available gene data bases in literature.


Absorption, distribution, metabolism, and excretion (ADME) impact chemical concentration and activation of molecular initiating events of Adverse Outcome Pathways (AOPs) in cellular, tissue, and organ level targets. In order to better describe ADME parameters and how they modulate potential hazards posed by chemical exposure, our goal is to investigate the relationship between AOPs and ADME related genes and functional information. Given the scope of this task, we began using hepatic steatosis as a case study. To identify ADME genes related to steatosis, we used the publicly available toxicogenomics database, Open TG-GATEsTM. This database contains standardized rodent chemical exposure data from 170 chemicals (mostly drugs), along with differential gene expression data and corresponding associated pathological changes. We examined the chemical exposure microarray data set gathered from 9 chemical exposure treatments resulting in pathologically confirmed (minimal, moderate and severe) incidences of hepatic steatosis. From this differential gene expression data set, we utilized differential expression analyses to identify gene changes resulting from the chemical exposures leading to hepatic steatosis. We then selected differentially expressed genes (DEGs) related to ADME by filtering all genes based on their ADME functional identities. These DEGs include enzymes such as cytochrome p450, UDP glucuronosyltransferase, flavin-containing monooxygenase and transporter genes such as solute carriers and ATP-binding cassette transporter families. The up and downregulated genes were identified across these treatments. Total of 61 genes were upregulated and 68 genes were down regulated in all treatments. Meanwhile, 25 genes were both up regulated and downregulated across all the treatments. This work highlights the application of bioinformatics in linking AOPs with gene modulations specifically in relationships to ADME and exposures to chemicals. This abstract does not necessarily reflect U.S. EPA policy.

Record Details:

Product Published Date: 03/15/2018
Record Last Revised: 06/20/2018
OMB Category: Other
Record ID: 341273